Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 1/2019

Ausgabe 1/2019

Inhaltsverzeichnis ( 23 Artikel )

15.10.2018 | Review Article | Ausgabe 1/2019

Awakening the “guardian of genome”: reactivation of mutant p53

Akshay Binayke, Sarthak Mishra, Prabhat Suman, Suman Das, Harish Chander

23.10.2018 | Review Article | Ausgabe 1/2019

Autophagy and its potent modulators from phytochemicals in cancer treatment

Chao-Yue Sun, Qian-Yu Zhang, Guang-Juan Zheng, Bing Feng

16.11.2018 | Review Article | Ausgabe 1/2019

Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters

Laure Deyme, Dominique Barbolosi, Florence Gattacceca

11.10.2018 | Original Article | Ausgabe 1/2019

Clinical and in vitro studies of the correlation between MGMT and the effect of streptozocin in pancreatic NET

Susumu Hijioka, Keiichiro Sakuma, Masahiro Aoki, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Kazuo Hara, Yasushi Yatabe

15.10.2018 | Original Article | Ausgabe 1/2019

Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy

Jacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, Maria Paerregaard, Jonas Abrahamsson, Bendik Lund, Olafur Gisli Jonsson, Kaie Pruunsild, Goda Vaitkeviciene, Jukka Kanerva, Kjeld Schmiegelow, the Nordic Society of Paediatric Haematology and Oncology (NOPHO)

16.10.2018 | Original Article | Ausgabe 1/2019

Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients

Brittney R. Starling, Parag Kumar, Andrew T. Lucas, David Barrow, Laura Farnan, Laura Hendrix, Hugh Giovinazzo, Gina Song, Paola Gehrig, Jeannette T. Bensen, William C. Zamboni

24.10.2018 | Original Article | Ausgabe 1/2019

Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis

Yu Bai, Hai-wei Wu, Yan-hua Zhang

24.10.2018 | Original Article | Ausgabe 1/2019

Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats

Priyanka Arora, Courtney Huff Adams, Gary Gudelsky, Biplab DasGupta, Pankaj B. Desai

27.10.2018 | Original Article | Ausgabe 1/2019

Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers

Nathalie Rioux, Amy Kim, Darrell Nix, Todd Bowser, Markus Warmuth, Peter G. Smith, Joanne Schindler

27.10.2018 | Original Article | Ausgabe 1/2019

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Kristina Lindemann, Philip J. Beale, Emma Rossi, Jeff C. Goh, Michelle M. Vaughan, Meaghan E. Tenney, Julie K. Martyn, Dirkje Sommeijer, Jose L. Iglesias, Gabriel Kremmidiotis, Jeremy Simpson, Elizabeth Doolin, Tina C. Lavranos, Annabell Leske, Anneso S. Veillard, David Espinoza, Martin R. Stockler, Danny Rischin, For ANZGOG and HCRN Collaborative Groups

27.10.2018 | Original Article | Ausgabe 1/2019

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms

Akimitsu Maeda, Kei Irie, Hitoshi Ando, Ayako Hasegawa, Hiroya Taniguchi, Shigenori Kadowaki, Kei Muro, Masahiro Tajika, Masahiro Aoki, Kazuhide Inaguma, Masaki Kajita, Akio Fujimura, Shoji Fukushima

29.10.2018 | Original Article | Ausgabe 1/2019

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin, Tarık Demir, Murat Sarı, Ozlem Ozkul, Murat Araz, Aysun Fatma Doğan, Nazım Can Demircan, Sernaz Uzunoğlu, İrfan Çiçin, Bülent Erdoğan

30.10.2018 | Original Article | Ausgabe 1/2019 Open Access

Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer

Hironori Fujii, Yunami Yamada, Daichi Watanabe, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida, Akio Suzuki

30.10.2018 | Original Article | Ausgabe 1/2019

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Ece Esin, B. Oksuzoglu, A. Bilici, I. Cicin, O. Kostek, M. A. Kaplan, S. Aksoy, B. Y. Aktas, O. Ozdemir, A. Alacacioglu, D. Cabuk, A. T. Sumbul, A. Sakin, S. Paydas, E. Yetisir, O. Er, T. Korkmaz, N. Yildirim, T. Sakalar, H. Demir, M. Artac, M. Karaagac, H. Harputluoglu, E. Bilen, E. Erdur, S. Degirmencioglu, A. Aliyev, T. Cil, P. Olgun, G. Basaran, O. Gumusay, A. Demir, E. Tanrikulu, P. F. Yumuk, Inanc Imamoglu, B. Oyan, B. Cetin, V. Haksoyler, N. Karadurmus, I. Erturk, T. Evrensel, H. Yilmaz, I. Beypinar, M. Kocer, K. N. Pilanci, M. Seker, Y. Urun, N. Yildirim, T. Eren, U. Demirci, Turkish Oncology Group

01.11.2018 | Original Article | Ausgabe 1/2019

Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial

Koji Murono, Hiroshi Nagata, Kazuhiro Ishimaru, Shigenobu Emoto, Manabu Kaneko, Masaya Hiyoshi, Kazuhito Sasaki, Kensuke Otani, Yasutaka Shuno, Takeshi Nishikawa, Toshiaki Tanaka, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa, Kei Muro, Soichiro Ishihara

01.11.2018 | Original Article | Ausgabe 1/2019

Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA)

Nathalie Rioux, Sherri Smith, Manav Korpal, Morgan O’Shea, Sudeep Prajapati, Guo Zhu Zheng, Markus Warmuth, Peter G. Smith

07.11.2018 | Original Article | Ausgabe 1/2019

A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer

Yasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma, Masahiro Hirakawa, Yasuo Takahashi, Kyoko Hamaguchi, Koshi Fujikawa, Takayuki Nobuoka, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Ichiro Takemasa, Tetsuji Takayama

08.11.2018 | Original Article | Ausgabe 1/2019 Open Access

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics

I. Kümler, P. Grundtvig Sørensen, J. Palshof, E. Høgdall, W. Skovrider-Ruminski, S. Theile, A. Fullerton, P. G. Nielsen, B. Vittrup Jensen, D. L. Nielsen

08.11.2018 | Original Article | Ausgabe 1/2019

Steroidal dimer by001 inhibits proliferation and migration of esophageal cancer cells via multiple mechanisms

Sai-Qi Wang, Kai-Rui Zhou, Xiao-Li Shi, Hui-Fang Lv, Liang-Yu Bie, Wei-Jie Zhao, Xiao-Bing Chen

08.11.2018 | Original Article | Ausgabe 1/2019 Open Access

Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma

Robin L. Jones, Gary Mo, John R. Baldwin, Patrick M. Peterson, Robert L. Ilaria Jr., Ilaria Conti, Damien M. Cronier, William D. Tap

09.11.2018 | Original Article | Ausgabe 1/2019 Open Access

Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study

Kazuo Sato, Yasuharu Toyoshima, Shiho Moriyama, Yutaka Endo, Tetsuhide Ito, Emiko Ohki

03.12.2018 | Short Communication | Ausgabe 1/2019 Open Access

Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients

W. Venus So, Tai-Hsien Ou Yang, Xing Yang, Jianguo Zhi

10.12.2018 | Correction | Ausgabe 1/2019

Correction to: Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice

Soumaya Labidi, Nesrine Mejri, Houda El Benna, Mehdi Afrit, Sarra Lakhdher, Hamouda Boussen

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise